Recall Register

Food, drugs, devices › Quidel Corporation

Device recall: QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.

FDA enforcement event 98709 · Class II · initiated 6 Apr 2026 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordSan Diego, CA

Quidel Corporation (San Diego, CA) initiated this device recall on 6 Apr 2026; FDA lists 1 product record under event 98709, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 572 device enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Quidel Corporation has 13 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Quidel Corporation, San Diego, CA.

Reason for recall

"Product has the potential for false positive results"

Distribution

"US Nationwide distribution in the states of AL, CA, FL, ID, IL, LA, MA, MD, MN, MO, NY, PA, SC, TN, TX, VA."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2169-2026QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.12279 unitsClass IIOngoing20 May 2026

Context

87%of 2026 device events are Class II572 events that year
1product record in this eventfirm median: 1
13events on this register for the firm

Other enforcement events for Quidel Corporation

InitiatedProduct (first record)TypeClassRecords
17 Jun 2025QuickVue: Dipstick Strep A Test: 50T, REF: 20108; 25T, REF: 20125; 50T, SCN, REF: 20108SCDeviceClass II1
5 Mar 2024QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 TestsDeviceClass II2
3 Jan 2024The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 DeviceClass II1
1 Feb 2023MicroVue C1-Inhibitor Plus EIA for measuring the amount of functional C1-lnhibitor protein in human plasma or serum, CatDeviceClass II1
13 Aug 2021Lyra Direct SARS-CoV-2 Assay Emergency Use Authorization- Ref: M124. The Lyra Direct SARS-CoV-2 Assay is a real-time RT-DeviceClass II1
27 Apr 2021Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagentDeviceClass I1
25 Sep 2020QUIDEL Sofia SARS Antigen FIA IVD REF 20374DeviceClass II1
17 Sep 2020Sofia SARS Antigen FIA Package Insert The Sofia SARS Antigen FIA is a lateral flow immunofluorescent sandwich assay thatDeviceClass II1
15 Dec 2017Sofia 2 Analyzer Catalog Number 20299 Sofia 2 is a bench top analyzer intended to be used with Cassette-based immunofluoDeviceClass II1
22 Jun 2017InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual,DeviceClass II1

All 13 events for Quidel Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Product has the potential for false positive results"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution in the states of AL, CA, FL, ID, IL, LA, MA, MD, MN, MO, NY, PA, SC, TN, TX, VA."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.